Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$109.18 - $185.98 $2,183 - $3,719
-20 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$54.34 - $94.85 $9,509 - $16,598
-175 Reduced 89.74%
20 $1,000
Q1 2020

May 14, 2020

BUY
$17.78 - $31.58 $3,467 - $6,158
195 New
195 $6,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track First National Bank Of South Miami Portfolio

Follow First National Bank Of South Miami and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of South Miami, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of South Miami with notifications on news.